share_log

12 Health Care Stocks Moving In Monday's Pre-Market Session

月曜日のプレマーケットセッションで動いているヘルスケアの12の株式

Benzinga ·  11/11 16:09

Gainers

  • CERo Therapeutics Hldgs (NASDAQ:CERO) stock rose 175.6% to $0.19 during Monday's pre-market session. The market value of their outstanding shares is at $28.9 million.
  • Nuwellis (NASDAQ:NUWE) shares increased by 27.07% to $2.3. The company's market cap stands at $4.2 million. As per the press release, Q3 earnings came out today.
  • RadNet (NASDAQ:RDNT) shares increased by 22.7% to $89.0. The market value of their outstanding shares is at $6.5 billion. The company's, Q3 earnings came out today.
  • Revelation Biosciences (NASDAQ:REVB) shares increased by 21.95% to $1.0. The company's market cap stands at $3.7 million. As per the press release, Q3 earnings came out yesterday.
  • Vigil Neuroscience (NASDAQ:VIGL) shares increased by 21.28% to $4.33. The market value of their outstanding shares is at $171.6 million. As per the press release, Q3 earnings came out 2 days ago.
  • Evotec (NASDAQ:EVO) shares increased by 19.37% to $4.93. The company's market cap stands at $1.7 billion. As per the news, the Q3 earnings report came out 3 days ago.

Losers

  • RAPT Therapeutics (NASDAQ:RAPT) shares declined by 48.1% to $1.5 during Monday's pre-market session. The company's market cap stands at $52.3 million.
  • Fresh2 Group (NASDAQ:FRES) shares decreased by 17.3% to $1.1. The company's market cap stands at $26.9 million.
  • Tivic Health Systems (NASDAQ:TIVC) shares declined by 15.55% to $0.34. The market value of their outstanding shares is at $2.1 million.
  • Dogwood Therapeutics (NASDAQ:DWTX) stock fell 13.73% to $3.71. The company's market cap stands at $4.9 million. As per the press release, Q3 earnings came out 2 days ago.
  • AbbVie (NYSE:ABBV) stock decreased by 10.68% to $178.2. The market value of their outstanding shares is at $314.6 billion.
  • SenesTech (NASDAQ:SNES) shares fell 8.46% to $2.6. The company's market cap stands at $2.6 million.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする